Medrx Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values JPY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
3,937
2,780
2,063
2,640
1,738
1,797
Total Accounts Receivable
26
29
29
48
26
28
Inventories
25
20
27
42
62
42
Other Current Assets
20
24
86
6
11
70
Total Current Assets
4,008
2,854
2,204
2,736
1,836
1,938
Net Property, Plant & Equipment
256
346
278
264
220
296
Total Investments and Advances
437
452
455
38
38
-
Intangible Assets
1
3
2
1
1
-
Other Assets
28
30
39
39
38
78
Total Assets
4,730
3,685
2,978
3,079
2,133
2,311
ST Debt & Current Portion LT Debt
99
-
-
-
-
Accounts Payable
-
-
3
1
-
Income Tax Payable
19
13
11
26
28
Other Current Liabilities
37
65
97
78
61
Total Current Liabilities
158
79
110
103
89
Long-Term Debt
-
-
-
395
-
Provision for Risks & Charges
-
8
8
9
9
Deferred Taxes
2
7
8
2
2
Other Liabilities
68
76
80
64
-
Total Liabilities
228
171
205
573
99
Common Equity (Total)
4,503
3,514
2,772
2,507
2,034
Total Shareholders' Equity
4,503
3,514
2,772
2,507
2,034
Total Equity
4,503
3,514
2,772
2,507
2,034
Liabilities & Shareholders' Equity
4,730
3,685
2,978
3,079
2,133

About Medrx Co.

View Profile
Address
431-7 Nishiyama
Higashikagawa Kagawa 769
Japan
Employees -
Website http://www.medrx.co.jp
Updated 07/08/2019
Medrx Co. Ltd. engages in the business of pharmaceutical drug development based on the transdermal absorption. It develops new value-added medicines by the drug formulation technology based on ILTS (Ionic Liquid Transdermal System), a unique technologies using ionic liquid. The company was founded by Masayoshi Matsumura on January 15, 2002 and is headquartered in Higashikagawa, Japan.